US Pharma Firms Facing 100% Tariffs - Negotiation Crucial
Pharmaceutical companies in the US must strike a deal to avoid punishing 100% tariffs, though generic drugs are exempt. Firms are scrambling to reach an agreement with the government.
The United States government has issued a stern warning to pharmaceutical companies: strike a deal or face crippling 100% tariffs on imported drugs. This unprecedented move is aimed at shaking up the industry and forcing pharmaceutical firms to the negotiating table.
The new order, however, does not affect generic medicines, which make up the majority of drugs consumed in the US. This provides some relief, as generics are often more affordable and accessible for American patients. But for the major brand-name drug manufacturers, the stakes have never been higher.
{{IMAGE_PLACEHOLDER}}Source: BBC News
